Treatment of antigen-activated CD8+ T cells with α-GalCer before adoptive transfer to tumor-bearing mice resulted in increased numbers of antigen-specific CD8+ T cells and cytotoxic activity; this effect involved iNKT and DC cells [94]. The gene discussed is CD8A; the disease is neoplasm.